Mechanisms of Parasite Dissemination in Visceral Leishmaniasis
内脏利什曼病寄生虫传播机制
基本信息
- 批准号:10062846
- 负责人:
- 金额:$ 54.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive Cell TransfersAdoptive TransferAnimalsBiteCachexiaCause of DeathCellsCessation of lifeChimera organismChronicClinicalColorConfocal MicroscopyCoupledCuesCutaneousDataDepositionDermisDevelopmentDinoprostoneDiseaseEpidemiologyEventFeverFlow CytometryGoalsHepatosplenomegalyHumanImpairmentIndividualInfectionInfectious Skin DiseasesInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjectionsInterleukin-1 betaInterventionInvestigationKnockout MiceLeadLeishmaniaLeishmania donovaniLeukocyte TraffickingLeukocytesLigandsLymphaticMalariaMalnutritionMediatingMinorityModelingMolecularMouse StrainsMusMyeloid CellsNeedlesOrganPancytopeniaParasitesParasitic infectionPathogenesisPharmacologyProcessProductionPublishingResearchRiskRisk FactorsRoleRouteSand FliesSiteSkinSplenomegalySymptomsTransgenic MiceTransgenic OrganismsVisceralVisceral LeishmaniasisWorkchemokineclinically relevantdraining lymph nodefeedinginflammatory milieuinhibitor/antagonistlatent infectionlymph nodesmigrationmonocytemouse modelneglected tropical diseasesneutrophilnovelnovel strategiespathogenreceptorrecruitresponsetraffickingtransmission processvectorvector transmission
项目摘要
Visceral leishmaniasis (VL), caused by the intracellular protozoan Leishmania donovani or L. infantum, is one of
the “Neglected Tropical Diseases” that impacts the poor of the world. People are infected when the parasite is
deposited in the dermis during the bloodmeal of the sand fly vector. The majority of people who are infected
develop a latent infection without clinical disease. However, some individuals develop a chronic progressive
infection characterized by fever, cachexia, massive splenomegaly, pancytopenia and ultimately death. The
mechanism of parasite dissemination from the skin and the reason that only a minority of infected individuals
develop full-blown disease are not understood, but malnutrition has been identified as a major risk factor for the
development of active disease. Progress in understanding the pathogenesis of VL has been hindered by the
lack of models suitable for study of parasite dissemination from the site of skin inoculation. The research
proposed here will use a clinically relevant animal host (malnourished mice) and natural parasite transmission
by the bite of an infected sand fly to define the mechanisms of parasite dissemination that lead to VL. Our central
hypothesis is that parasite dissemination is driven by altered cutaneous inflammation and myeloid cell-mediated
trafficking of the parasite from the skin to visceral organs. Our published and preliminary data suggest a three-
component model of parasite dissemination that involves (1) increased influx of inflammatory cells to the site of
parasite entry in the skin; (2) hyper-migration of infected myeloid cells (primarily monocytes and neutrophils)
from the skin, and (3) increased escape of migrating infected myeloid cells from the draining lymph node. We
propose that co-existent malnutrition- and vector-related inflammation, as would occur in endemic regions of the
world, will synergistically promote parasite dissemination and active VL. In Specific Aim 1 we will determine the
dynamics of early myeloid cell recruitment and parasite fate in the skin following infection by needle injection and
vector-transmission. Our working hypothesis is that dysregulated cutaneous inflammation, in response to
malnutrition or sand fly feeding, drives the altered dynamics of myeloid cell trafficking and pathogen capture in
the skin. In particular, we will determine how the dysregulated inflammation leads to differences in neutrophil
and inflammatory monocyte influx, parasite capture, and cell egress from the skin. In Specific Aim 2 we will
determine the mechanisms of myeloid cell trafficking and L. donovani dissemination from the skin to visceral
organs following needle injection and vector-transmission. Our working hypothesis is that increased myeloid cell
trafficking through the afferent lymphatic, coupled with reduced cell retention in the draining LN, leads to parasite
dissemination. Changes in inflammatory mediators and chemokines and their receptors are likely to underpin
parasite trafficking to the visceral organs. Understanding the mechanisms behind parasite visceralization can
lead to interventions to reduce the risk for parasite dissemination and development of this devastating disease.
内脏利什曼病 (VL) 由细胞内原生动物杜氏利什曼原虫或婴儿利什曼原虫引起,是以下疾病之一
影响世界贫困的“被忽视的热带病”当寄生虫感染时,人们就会受到感染。
沙蝇媒介的血粉沉积在真皮中,大多数人被感染。
出现潜伏感染但没有临床疾病,但有些人会出现慢性进行性感染。
感染的特征是发烧、恶病质、巨脾肿大、全血细胞减少并最终死亡。
寄生虫从皮肤传播的机制以及只有少数感染者的原因
发展为全面性疾病的原因尚不清楚,但营养不良已被确定为该疾病的主要危险因素
VL 发病机制的进展受到了阻碍。
缺乏适合研究皮肤接种部位寄生虫传播的模型。
这里提出将使用临床相关的动物宿主(营养不良的小鼠)和自然寄生虫传播
通过受感染白蛉的叮咬来确定导致 VL 的寄生虫传播机制。
假设是寄生虫传播是由改变的皮肤炎症和骨髓细胞介导的
我们已发表的初步数据表明,寄生虫从皮肤贩运到内脏器官的过程分为三个阶段。
寄生虫传播的组成模型涉及(1)炎症细胞流入部位的增加
寄生虫进入皮肤;(2)受感染的骨髓细胞(主要是单核细胞和中性粒细胞)过度迁移
(3) 迁移的受感染骨髓细胞从引流淋巴结逃逸的情况增加。
提出营养不良和媒介相关炎症同时存在,就像在流行地区发生的那样
世界,将协同促进寄生虫传播和活跃 VL 在具体目标 1 中,我们将确定
针注射感染后早期骨髓细胞募集和皮肤中寄生虫命运的动态
我们的工作假设是皮肤炎症失调,以应对
营养不良或白蛉进食,驱动骨髓细胞运输和病原体捕获的动态
特别是,我们将确定失调的炎症如何导致中性粒细胞的差异。
在具体目标 2 中,我们将讨论炎症性单核细胞流入、寄生虫捕获和细胞从皮肤中排出。
确定骨髓细胞运输和杜氏乳杆菌从皮肤到内脏传播的机制
针注射和载体传播后的器官我们的工作假设是骨髓细胞增加。
通过传入淋巴管的运输,加上引流淋巴结中细胞滞留的减少,导致寄生虫
炎症介质和趋化因子及其受体的变化可能是传播的基础。
了解寄生虫内脏化背后的机制可以帮助了解寄生虫向内脏器官的贩运。
采取干预措施,降低寄生虫传播和这种毁灭性疾病发展的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter C. Melby其他文献
Concentration of Pentostam in human breast milk.
人母乳中 Pentostam 的浓度。
- DOI:
10.1016/0035-9203(89)90327-1 - 发表时间:
1989-11-01 - 期刊:
- 影响因子:2.2
- 作者:
Jonathan D. Berman;Peter C. Melby;Franklin A. Neva - 通讯作者:
Franklin A. Neva
Peter C. Melby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter C. Melby', 18)}}的其他基金
Physician-Scientist Training in Emerging Infectious Diseases
新发传染病的医师科学家培训
- 批准号:
10270872 - 财政年份:2021
- 资助金额:
$ 54.82万 - 项目类别:
Physician-Scientist Training in Emerging Infectious Diseases
新发传染病的医师科学家培训
- 批准号:
10647762 - 财政年份:2021
- 资助金额:
$ 54.82万 - 项目类别:
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis
内脏利什曼病寄生虫传播机制
- 批准号:
10302274 - 财政年份:2017
- 资助金额:
$ 54.82万 - 项目类别:
Malnutrition-related Lymph Node Dysfunction and Risk of Visceral Leishmaniasis
营养不良相关的淋巴结功能障碍和内脏利什曼病的风险
- 批准号:
8702843 - 财政年份:2014
- 资助金额:
$ 54.82万 - 项目类别:
Discovery of 4-aminoquinoline therapeutics for visceral leishmaniasis
发现内脏利什曼病的 4-氨基喹啉疗法
- 批准号:
8207443 - 财政年份:2010
- 资助金额:
$ 54.82万 - 项目类别:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
内脏利什曼病中的 NOS2 和精氨酸酶 - FIRCA 补充剂
- 批准号:
7758284 - 财政年份:2009
- 资助金额:
$ 54.82万 - 项目类别:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
内脏利什曼病中的 NOS2 和精氨酸酶 - FIRCA 补充剂
- 批准号:
8012292 - 财政年份:2009
- 资助金额:
$ 54.82万 - 项目类别:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
内脏利什曼病中的 NOS2 和精氨酸酶 - FIRCA 补充剂
- 批准号:
7559198 - 财政年份:2009
- 资助金额:
$ 54.82万 - 项目类别:
NOS2 and arginase in visceral leishmaniasis
内脏利什曼病中的 NOS2 和精氨酸酶
- 批准号:
6922649 - 财政年份:2005
- 资助金额:
$ 54.82万 - 项目类别:
NOS2 and arginase in visceral leishmaniasis
内脏利什曼病中的 NOS2 和精氨酸酶
- 批准号:
7009285 - 财政年份:2005
- 资助金额:
$ 54.82万 - 项目类别:
相似海外基金
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
PI3K 靶向 T 细胞介导的持久抗肿瘤免疫机制
- 批准号:
10682190 - 财政年份:2023
- 资助金额:
$ 54.82万 - 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10502136 - 财政年份:2022
- 资助金额:
$ 54.82万 - 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10683384 - 财政年份:2022
- 资助金额:
$ 54.82万 - 项目类别: